StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
88
This year
4
Publishing Date
2023 - 09 - 28
1
2023 - 09 - 14
1
2023 - 09 - 06
1
2023 - 09 - 05
1
2023 - 08 - 29
1
2023 - 08 - 10
1
2023 - 08 - 07
2
2023 - 06 - 29
1
2023 - 06 - 16
1
2023 - 05 - 24
1
2023 - 05 - 23
1
2023 - 05 - 19
1
2023 - 05 - 15
2
2023 - 05 - 11
1
2023 - 05 - 04
1
2023 - 05 - 03
4
2023 - 05 - 02
3
2023 - 05 - 01
1
2023 - 04 - 30
3
2023 - 04 - 28
2
2023 - 04 - 26
1
2023 - 04 - 20
1
2023 - 04 - 11
1
2023 - 03 - 01
1
2023 - 02 - 24
1
2023 - 02 - 21
1
2023 - 02 - 17
1
2023 - 02 - 07
1
2023 - 01 - 09
1
2023 - 01 - 04
1
2022 - 12 - 07
1
2022 - 11 - 08
1
2022 - 11 - 07
1
2022 - 11 - 04
1
2022 - 10 - 17
1
2022 - 10 - 14
1
2022 - 10 - 11
1
2022 - 09 - 30
1
2022 - 08 - 24
1
2022 - 08 - 01
1
2022 - 07 - 07
1
2022 - 07 - 06
1
2022 - 07 - 05
1
2022 - 06 - 08
1
2022 - 05 - 05
1
2022 - 04 - 28
1
2022 - 04 - 14
1
2022 - 04 - 13
1
2022 - 03 - 14
1
2022 - 03 - 10
1
2022 - 03 - 09
1
2022 - 01 - 06
1
2022 - 01 - 05
2
2022 - 01 - 04
1
2021 - 12 - 21
2
2021 - 12 - 16
1
2021 - 10 - 26
1
2021 - 10 - 06
2
2021 - 10 - 04
1
2021 - 09 - 28
1
Sector
Consumer services
1
Finance
5
Health technology
88
Manufacturing
6
N/a
7
Process industries
1
Retail trade
1
Technology services
1
Tags
Acquire
1
Acquisition
4
Agreement
2
Air
1
Alliances
1
America
1
Antibiotics
2
Antibody
1
Biopharma
3
Biotechnology
6
Breast
1
Business
4
Can106
1
Cancer
4
Car-t
1
Ceo
4
Ces
1
Change
1
Chinese
1
Clinical-trials-phase-ii
2
Clinical-trials-phase-iii
1
Collaboration
2
Commercialization
1
Companies
1
Company
1
Conference
1
Covid-19
1
Disease
3
Drug
3
Europe
4
Events
3
Extension
1
Eye
1
Fda-approvals
1
Financial
2
First
2
Fucaso
1
Global
12
Growth
5
Influenza
2
Market
18
Money
2
Mrna
2
N/a
54
People
10
Pharma
11
Pharmaceutical
2
Rare
2
Report
13
Research
8
Results
6
Sanofi
5
Study
2
Technology
2
Therapeutics
8
Treatment
3
Trends
2
Update
2
Vaccine
2
Week
3
Entities
Abbott laboratories
1
Abbvie inc.
4
Ahren acquisition corp.
2
Alnylam pharmaceuticals, inc.
1
Amgen inc.
1
Aridis pharmaceuticals inc.
1
Astellas pharma inc
2
Astrazeneca plc
8
Bank of montreal
3
Bausch health companies inc.
1
Biontech se
2
Bristol-myers squibb company
3
Byline bancorp, inc.
2
Contrafect corporation
1
Dada nexus limited
1
Danaher corporation
1
Eli lilly and company
5
Enanta pharmaceuticals, inc.
1
First wave biopharma, inc.
2
Fox corporation
1
Fulcrum therapeutics, inc.
1
Gilead sciences, inc.
1
Glaxosmithkline plc
5
Glycomimetics, inc.
1
Icosavax inc
1
Immune therapeutics, inc.
1
Innate pharma s.a.
8
Innate pharma sa
8
Jd.com, inc.
1
Johnson & johnson
8
Mobiv acquisition corp
2
Morphosys ag
1
Neubase therapeutics, inc.
1
Neuropathix, inc.
1
Newamsterdam pharma co b.v.
1
Novartis ag
5
Novo nordisk a/s
7
Orchard therapeutics plc
1
Pegasus digital mobility acquisition corp.
2
Pfizer, inc.
2
Pieris pharmaceuticals, inc.
1
Precision biosciences, inc.
1
Provention bio, inc.
14
Rcf acquisition corp.
4
Regeneron pharmaceuticals, inc.
2
Replimune group, inc.
1
Rpm international inc.
1
Sangamo therapeutics, inc.
1
Sanofi
88
Shoulderup technology acquisition corp.
1
Takeda pharmaceutical company limited
2
Teva pharmaceutical industries limited
1
Teva pharmaceutical industries ltd
1
Ucb s.a.
1
Uniqure n.v.
1
Vertex pharmaceuticals incorporated
1
Viatris inc.
1
Voyager therapeutics, inc.
1
Symbols
AAPL
26
ABB
49
ABLZF
43
ABT
56
ACB
28
ALLT
23
AMSIY
27
AMSYF
27
ARCXF
27
ARVL
108
BNPQF
31
BNPQY
31
CRCW
24
CSCO
44
CTLT
26
DHR
32
DOW
38
ERIC
56
F
23
FNCTF
152
FSM
33
GE
34
GOOG
35
GOOGL
35
HIMX
27
HITI
82
HON
78
HUIZ
26
IBM
31
IDYA
35
INTC
31
JG
89
JNJ
97
KBR
53
LLY
29
MDT
44
MS
95
MSFT
39
MT
37
NIO
41
NIOIF
28
NOKBF
23
NVO
29
NVS
33
NVSEF
30
ORCL
32
PCRFF
24
PCRFY
24
PHG
46
PPRUF
40
PPRUY
40
RDWR
23
SAP
68
SAPGF
56
SNY
105
SNYNF
88
TEVJF
23
TLRY
26
TMO
54
XM
26
Exchanges
Nasdaq
88
Nyse
29
Crawled Date
2023 - 10 - 17
1
2023 - 10 - 11
1
2023 - 09 - 28
1
2023 - 09 - 14
1
2023 - 09 - 06
1
2023 - 09 - 05
1
2023 - 08 - 29
1
2023 - 08 - 10
1
2023 - 08 - 07
2
2023 - 06 - 29
1
2023 - 06 - 16
1
2023 - 05 - 24
1
2023 - 05 - 23
1
2023 - 05 - 19
1
2023 - 05 - 15
2
2023 - 05 - 11
1
2023 - 05 - 04
1
2023 - 05 - 03
4
2023 - 05 - 02
3
2023 - 05 - 01
4
2023 - 04 - 28
2
2023 - 04 - 26
1
2023 - 04 - 20
1
2023 - 04 - 11
1
2023 - 03 - 01
1
2023 - 02 - 24
1
2023 - 02 - 21
1
2023 - 02 - 17
1
2023 - 02 - 07
1
2023 - 01 - 09
1
2023 - 01 - 04
1
2022 - 12 - 07
1
2022 - 11 - 08
1
2022 - 11 - 07
1
2022 - 11 - 04
1
2022 - 10 - 17
1
2022 - 10 - 14
1
2022 - 10 - 11
1
2022 - 09 - 30
1
2022 - 08 - 24
1
2022 - 08 - 01
1
2022 - 07 - 07
1
2022 - 07 - 06
1
2022 - 07 - 05
1
2022 - 06 - 08
1
2022 - 05 - 05
1
2022 - 04 - 28
1
2022 - 04 - 14
1
2022 - 04 - 13
1
2022 - 03 - 14
1
2022 - 03 - 10
1
2022 - 03 - 09
1
2022 - 01 - 06
3
2022 - 01 - 04
1
2021 - 12 - 21
2
2021 - 12 - 16
1
2021 - 10 - 26
1
2021 - 10 - 06
2
2021 - 10 - 04
1
2021 - 09 - 28
1
Crawled Time
00:00
103
00:20
20
01:00
84
02:00
47
03:00
34
04:00
27
04:20
14
05:00
65
06:00
103
07:00
120
08:00
91
08:20
4
09:00
92
10:00
88
11:00
218
12:00
255
12:15
9
12:20
70
12:30
41
13:00
217
13:15
8
13:20
59
13:30
56
14:00
184
14:15
12
14:20
48
14:30
56
15:00
152
15:15
6
15:20
50
15:30
66
16:00
181
16:20
26
17:00
189
18:00
148
19:00
120
20:00
118
20:20
18
21:00
159
22:00
130
23:00
102
Source
spacfeed.com
13
www.biospace.com
34
www.globenewswire.com
7
www.modeln.com
3
www.prnewswire.com
31
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
SNYNF
crawled time :
10:00
save search
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline
Published:
2024-03-14
(Crawled : 10:00)
- globenewswire.com
FWBI
|
$2.98
-1.33%
-1.34%
50K
|
Manufacturing
|
-53.75%
|
O:
-3.52%
H:
0.16%
C:
-14.76%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-5.07%
|
O:
0.23%
H:
0.0%
C:
0.0%
first
business
pipeline
biopharma
Net Zero Strategies in the Media Sector: 2024 Thematic Research Report - 15/20 Companies Analyzed have Set Either a Short or Long-term Target to Reduce their Emissions
Published:
2024-03-08
(Crawled : 10:00)
- prnewswire.com
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.64%
|
O:
-0.08%
H:
0.0%
C:
0.0%
FOXA
|
$30.46
0.2%
0.2%
2.1M
|
Consumer Services
|
6.07%
|
O:
0.17%
H:
0.98%
C:
0.52%
FOX
|
$27.985
0.13%
-0.61%
1M
|
Consumer Services
|
7.05%
|
O:
0.19%
H:
0.99%
C:
0.61%
media
companies
report
research
set
Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI foundation model for biology
Published:
2024-02-20
(Crawled : 10:00)
- biospace.com/
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-0.25%
|
O:
2.72%
H:
0.0%
C:
-0.8%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-0.78%
|
O:
2.53%
H:
0.0%
C:
0.0%
first
universal
Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published:
2024-02-09
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-12.38%
|
O:
-0.91%
H:
3.88%
C:
3.88%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
8.24%
|
O:
-2.6%
H:
2.26%
C:
1.44%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-9.35%
|
O:
-2.46%
H:
0.0%
C:
0.0%
ALPMY
|
$9.34
-1.11%
690K
|
Manufacturing
|
-12.95%
|
O:
4.66%
H:
0.0%
C:
-3.92%
PFE
A
|
$25.42
-1.05%
-0.04%
44M
|
Health Technology
|
-6.82%
|
O:
-0.04%
H:
0.11%
C:
0.0%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-8.43%
|
O:
-0.37%
H:
0.21%
C:
0.05%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-6.81%
|
O:
0.33%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-0.48%
|
O:
1.11%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
7.47%
|
O:
-1.28%
H:
1.05%
C:
-0.72%
research
global
market
Global Times: Path to modernity: 45 years on, continuous reform and opening-up underpins pursuit of Chinese modernization
Published:
2023-12-20
(Crawled : 10:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-4.02%
|
O:
-0.39%
H:
1.49%
C:
0.32%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-5.75%
|
O:
0.21%
H:
0.0%
C:
0.0%
global
chinese
Innate Pharma Announces Leadership Change - December 18, 2023
Published:
2023-12-18
(Crawled : 10:00)
- biospace.com/
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.14%
|
O:
1.25%
H:
0.0%
C:
0.0%
IPHA
|
$2.35
-9.27%
-10.21%
16K
|
Health Technology
|
7.47%
|
O:
2.9%
H:
2.02%
C:
-1.21%
pharma
change
AQEMIA Announces a Major Multi-year Collaboration of $140 Million With Sanofi
Published:
2023-12-05
(Crawled : 10:00)
- biospace.com/
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-1.9%
|
O:
0.27%
H:
0.12%
C:
0.12%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-1.96%
|
O:
-0.5%
H:
0.0%
C:
0.0%
multi-year
collaboration
sanofi
Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round
Published:
2023-11-14
(Crawled : 10:00)
- biospace.com/
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
1.08%
|
O:
0.68%
H:
0.0%
C:
0.0%
series
Global Enterprise Artificial Intelligence Market Forecast Report: Enterprise AI Market to Surge, Predicted to Hit $1.89 Billion by 2030
Published:
2023-11-13
(Crawled : 10:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
1.78%
|
O:
-0.12%
H:
0.0%
C:
0.0%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
8.87%
|
O:
-0.23%
H:
0.6%
C:
0.6%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-0.41%
|
O:
-1.48%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
8.07%
|
O:
0.06%
H:
1.08%
C:
0.78%
intelligence
global
market
Lecheng, MSD vow to deepen medical cooperation
Published:
2023-11-10
(Crawled : 10:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
0.48%
|
O:
-1.28%
H:
0.0%
C:
0.0%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-3.72%
|
O:
-1.24%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-0.74%
|
O:
-0.32%
H:
0.0%
C:
0.0%
medical
Global ELISA Analyzers Market Report 2023-2028 with Competitive Analysis of Thermo Fisher Scientific, Abcam, Bio-Rad Labs, Merck, F. Hoffmann-La Roche, Danaher, BioTech, Agilent, QIAGEN, & PerkinElmer
Published:
2023-10-27
(Crawled : 10:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-12.48%
|
O:
-18.18%
H:
0.0%
C:
0.0%
DHR
|
$239.39
-0.4%
0.03%
2.9M
|
Health Technology
|
24.09%
|
O:
-0.73%
H:
0.61%
C:
-2.28%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-13.68%
|
O:
-15.73%
H:
0.0%
C:
0.0%
report
global
market
Global Acute Myeloid Leukemia (AML) Treatment Market Trends Analysis Report 2023-2028 - Personalized Medicine and Patient Advocacy Drive Opportunities
Published:
2023-10-20
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-26.37%
|
O:
-4.45%
H:
0.0%
C:
0.0%
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-14.92%
|
O:
-3.95%
H:
0.0%
C:
-0.72%
ALPMY
|
$9.34
-1.11%
690K
|
Manufacturing
|
-25.1%
|
O:
-2.89%
H:
3.67%
C:
2.85%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
12.88%
|
O:
0.42%
H:
0.54%
C:
0.11%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-12.53%
|
O:
-0.17%
H:
0.0%
C:
0.0%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-4.99%
|
O:
0.0%
H:
0.16%
C:
-0.64%
report
treatment
global
trends
leukemia
market
Press Release: Sanofi delivers first medicines from Global Health Unit’s Impact brand portfolio
Published:
2023-10-19
(Crawled : 10:00)
- globenewswire.com
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-14.64%
|
O:
-2.42%
H:
0.0%
C:
0.0%
health
global
impact
sanofi
Tessellate BIO Emerges from StealthThe Next Generation Synthetic Lethality Precision Oncology Company
Published:
2023-10-17
(Crawled : 10:00)
- biospace.com/
NAMS
|
$19.95
2.31%
2.26%
100K
|
n/a
|
156.24%
|
O:
2.37%
H:
0.0%
C:
-3.98%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-16.04%
|
O:
-0.4%
H:
0.0%
C:
0.0%
REPL
|
$7.22
0.98%
0.97%
1.1M
|
Health Technology
|
-51.19%
|
O:
-1.02%
H:
4.14%
C:
2.48%
company
4 Common Questions Answered About the New Monoclonal Antibody to Help Prevent Severe RSV in Babies
Published:
2023-10-11
(Crawled : 10:00)
- prnewswire.com
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-15.44%
|
O:
1.1%
H:
0.0%
C:
0.0%
antibody
rsv
IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023
Published:
2023-09-28
(Crawled : 10:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-14.71%
|
O:
-2.28%
H:
0.0%
C:
-0.06%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-14.98%
|
O:
-1.61%
H:
0.0%
C:
0.0%
fucaso
car-t
First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi
Published:
2023-09-14
(Crawled : 10:00)
- globenewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-14.29%
|
O:
2.14%
H:
0.0%
C:
-1.3%
FWBI
|
$2.98
-1.33%
-1.34%
50K
|
Manufacturing
|
-65.3%
|
O:
109.38%
H:
21.84%
C:
-44.24%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-15.42%
|
O:
0.26%
H:
0.74%
C:
0.33%
license
biopharma
global
agreement
sanofi
Nucleome Therapeutics appoints Dr Russell Greig as Non-Executive Chair of the Board
Published:
2023-09-06
(Crawled : 10:00)
- biospace.com/
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-13.73%
|
O:
-0.83%
H:
0.19%
C:
-0.09%
therapeutics
Didier Landais is appointed 4P-Pharma's CEO to lead the company into a new chapter of its development
Published:
2023-09-05
(Crawled : 10:00)
- biospace.com/
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-14.53%
|
O:
-0.93%
H:
0.0%
C:
0.0%
ceo
Confo Therapeutics Appoints Dieter Weinand, Former CEO of Bayer Pharmaceuticals, as Independent Chairman
Published:
2023-08-29
(Crawled : 10:00)
- biospace.com/
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-14.76%
|
O:
0.34%
H:
0.0%
C:
0.0%
ceo
therapeutics
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.